This is not the most recent version of the article. View current version (21 JAN 2009)

Intervention Protocol

Aldose reductase inhibitors for the treatment of diabetic polyneuropathy

  1. C Chalk,
  2. TJ Benstead,
  3. F Moore

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 18 JUL 2007

DOI: 10.1002/14651858.CD004572

How to Cite

Chalk C, Benstead TJ, Moore F. Aldose reductase inhibitors for the treatment of diabetic polyneuropathy (Protocol). Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD004572. DOI: 10.1002/14651858.CD004572.

Author Information

*Dr Colin Chalk, Dept. of Neurology and Neurosurgery, McGill University, Montreal General Hospital - Room L7313, 1650 Cedar Avenue, Montreal, Quebec, H3G 1A4, CANADA. colin.chalk@staff.mcgill.ca.

Publication History

  1. Published Online: 18 JUL 2007

SEARCH

This is not the most recent version of the article.View current version (21 Jan 2009)

  1. Current Version

    Aldose reductase inhibitors for the treatment of diabetic polyneuropathy

    Colin Chalk, Tim J Benstead and Fraser Moore

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD004572.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Aldose reductase inhibitors for the treatment of diabetic polyneuropathy

    C Chalk, TJ Benstead and F Moore

    Article first published online: 18 JUL 2007 | DOI: 10.1002/14651858.CD004572